The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Norepinephrine Bitartrate In Sodium Chloride
Norepinephrine Bitartrate · NOREPINEPHRINE BITARTRATE .064 mg/mL · Injection, Solution · Intravenous · WG Critical Care, LLC
NDC 44567-0642-10 · 10 BAG in 1 CARTON / 250 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$79.00
Reported to Texas DSHS · 2026 annual filing · WG Critical Care
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- InfoRLife SASwitzerlandmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA215700
- TE code
- —
- Approval date
- Sep 15, 2022
- Patents / exclusivity
- 10 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 10888534 | Apr 26, 2039 |
| patent | 10888534 | Apr 26, 2039 |
| patent | 10888534 | Apr 26, 2039 |
| patent | 10888534 | Apr 26, 2039 |
| patent | RE49443 | Feb 26, 2035 |
| patent | RE49443 | Feb 26, 2035 |
| patent | RE49422 | Feb 26, 2035 |
| patent | RE49422 | Feb 26, 2035 |
| patent | RE49422 | Feb 26, 2035 |
| patent | RE49422 | Feb 26, 2035 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Norepinephrine Bitartrate (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE 4 mg/250mL | Jul 15, 2026 | Sep 3, 2026 |
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE 8 mg/250mL | Jul 15, 2026 | Sep 3, 2026 |
| Avenacy, LLC | NOREPINEPHRINE BITARTRATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | NOREPINEPHRINE BITARTRATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NOREPINEPHRINE BITARTRATE .128 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NOREPINEPHRINE BITARTRATE .016 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NOREPINEPHRINE BITARTRATE .064 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| WG Critical Care, LLC | NOREPINEPHRINE BITARTRATE .032 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | NOREPINEPHRINE BITARTRATE 16 mg/250mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Norepinephrine Bitartrate In Sodium Chloride — NDC 44567-0642-10," retrieved September 3, 2026, https://drugdashboards.com/drug/44567064210.
Free to cite with attribution — see how the data is put together.